We Support Czech Psychedelic Research

About us

The foundation was established to support research and study of psychedelic substances and their use in pharmacology, psychology, addictology and psychiatry.

The founder is Společnost pro podporu neurovědního výzkumu s.r.o. (the Society for the Support of Neuroscience Research). At present, the members of the Management Board are Václav Dejčmar, Ondřej Fryc and Yemi A.D.

The purpose of the foundation is primarily to support research institutes and teams in the Czech Republic that study psychedelic substances.

The fundation is primarily intended to support studies in the fields of pharmacology, neurobiology, primary and secondary prevention of risky use, psychology, addictology and psychiatry, which deal with the mechanism of action of the psychotropic effects of these substances. In a broader context, the fund also supports social science projects focused on cultural consequences and the history of psychedelic use.

Annual reports

Our Team


MUDr. Tomáš Paleníček, Ph.D. Founder

Graduate of the 3rd Faculty of Medicine at Charles University in the field of general medicine and postgraduate studies in neuroscience. In his career, he specializes in research into the effects of psychedelics and other psychoactive substances. His team's research covers a wide range of topics - from cell cultures through animal experiments to studies on healthy volunteers and patients. In his clinical practice, he focuses mainly on general psychiatry.

MUDr. Martin Brunovský, Ph.D. Founder

Neuroscientist, neurologist and Head of department of Applied Brain Electrophysiology at National Institute of Mental Health, Czech Republic. The research interest involves the application of brain imaging techniques, particularly quantitative electroencephalography, in the evaluation of CNS drug effects with the aim of better prediction of response to psychopharmacological treatment.

Prof. MUDr. Jiří Horáček, Ph.D., FCMA, Founder

Neuroscientist, psychiatrist and psychotherapist, Head of the Department of Psychiatry and Medical Psychology at the 3rd Faculty of Medicine, Charles University, and Deputy Director of the National Institute of Mental Health, CR. His research activities involve psychedelic studies, theory of consciousness, and brain imaging.

Executive & PR

Mgr. Vladěna Sobasová Executive director

Addictologist, coordinator of research projects at the National Institute of Mental Health, in the past worked as a clerk in the Secretariat of the Government Council for the Coordination of Drug Policy (Office of the Government of the Czech Republic). She has participated in the organization of national conferences on addictology and since 2016 she has been part of the local team of organizers of the European Conference on Mental Health (ECMH).

Bc. Eva Césarová PR & media

Co-founder of the Czech Psychedelic Society, organizer of events with psychedelic topics, media representative of psychedelic research at the National Institute of Mental Health and a student of Addictology at the 1st Faculty of Medicine, Charles University.

Management Board

Ing. Václav Dejčmar Chairman of the management board

Economist and philanthropist, investor in financial and private equity projects around RSJ, co-owner of the Dox Prague Center for Contemporary Art and occasional producer, including I am Fishead about the role of psychopaths in business and politics or Bufo Alvarius - The Underground Secret about the strongest known natural psychedelic . He likes to deal with disruptive thoughts and is convinced of the fundamental societal significance of the psychedelic renaissance.

Yemi A.D. Member of of the management board

Multidisciplinary creator, founder and CEO of JAD Production. Dancer, choreographer, director, producer, actor, one of the most sought after creatives in his field. For example, he worked with Kanye West, built an extensive list of clients, including Google, Coca Cola and T-Mobile. Produces custom projects and brands and spoke on several platforms.

Ing. Ondřej Fryc Member of of the management board

Lifelong adventurer and businessman. He traveled around the world with his backpack, founded several companies (the best known is Mall.cz) and, through his investment fund Reflex Capital, invests in promising Czech projects and entrepreneurs. He and his wife Tereza raise three children and support a number of non-profit activities with a social impact.

Scientific Board

MUDr. Filip Tylš, Ph.D. Chairman of the scientific board

Psychiatrist / neuroscientist at the National Institute of Mental Health (NIMH), executive manager and founder of the Psyon - Psychedelic Clinic (www.psyon.cz), founder of the Czech Psychedelic Society (CZEPS) and a psychotherapist in private practice. He is a graduate of the 1st Faculty of Medicine (MD) and neuroscience at the 3rd Faculty of Medicine, (PhD) at Charles University. He completed training in gestalt psychotherapy (IVGT Prague 2020) and psychedelic training "CPTR" (CIIS, San Francisco, 2018). He specializes in psychedelic-assisted psychotherapy and psychedelic research.

Ingmar Gorman, Ph.D. Member of the scientific board

Dr. Ingmar Gorman is a psychologist who specializes in Psychedelic Harm Reduction and Integration. He is the co-founder of Fluence (www.fluence8.com), a psychedelic education company training mental health providers in psychedelic treatments. Dr. Gorman is also site co-principal investigator and therapist Phase 2 & 3 clinical trials of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder (www.mdmaptsd.org).

Prof. Tania Re Member of the scientific board

Has a degree in Clinical and Community Psychology, specializes in Gestalt Psychotherapy at the CSTG in Milan and as a complementary therapist in Switzerland, deepening the study and practice of bio-natural disciplines. Her field research is carried out in South America in indigenous communities by studying traditional medicines, plants and healing rituals. In recent years, he has focused his research interests on the use of "master plants" in the therapeutic field in collaboration with universities and research centers in Europe, the United States and South America. In Italy she promotes the therapeutic use of psychotropic substances in collaboration with the Luca Coscioni Association of which she is a Councilor.

Prof. Dr. Jan Ramaekers, Ph.D. Member of the scientific board

Professor of Psychopharmacology and Behavioral Toxicology, University of Maastricht (Netherlands). He is engaged in research in the field of psychopharmacology, addiction, drugs and traffic psychology.

doc. Ing. Martin Kuchař, Ph.D. Member of the scientific board

A bioorganic chemist, who has been trained in the forensic toxicology and neuropsychopharmacological research for more than 10 years. In the field of psychedelic substances with a focus on the synthesis of pure alkaloids, their metabolism and pharmacological characteristics with the potential to their use in psychiatric practice. He is an active member of the International Forensic Toxicological Society and tries to transpose current scientific knowledge into legislative narcotics and psychotropic substances.


Who are our

Lumír Kraina

Frank Zanow CEO / New Business ANT-Neuro

Yemi A.D. Multidisciplinary creator, founder and CEO of JAD Production.

Václav Dejčmar Economist and philanthropist, investor in financial and private equity projects around RSJ, co-owner of the Dox Prague Center for Contemporary Art

Ondřej Fryc Owner of the investment fund Reflex Capital

Jarmila Mucha Plocková Granddaughter of Alfons Mucha, architect, artist


Receive news about foundation activities and about news from the research of psychedelics.